IN8BIO ANNOUNCES PRICING OF PRIVATE PLACEMENT OF UP TO $40.2 MILLION TO ADVANCE NOVEL GAMMA-DELTA T CELL ENGAGER
IN8BIO INC: INITIAL PROCEEDS EXTEND CASH RUNWAY INTO FIRST HALF OF 2027
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.